Company / EPS (Diluted)
Senti Biosciences Holdings, Inc. EPS (Diluted) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$12.03
FY2025
5-year range
-$19.00 / -$2.23
FY2022-FY2025
Trend
+24.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-2.23 to $-12.03 over the past 2 years.
Based on SEC 10-K filings.
-12.03 in FY2025.
Declined from $-2.23 to $-12.03 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 24.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.03 | +24.9% |
| FY2024 | -$16.01 | -617.9% |
| FY2023 | -$2.23 | +88.3% |
| FY2022 | -$19.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026